Next Article in Journal
Concurrent Inhibition of Akt and ERK Using TIC-10 Can Overcome Venetoclax Resistance in Mantle Cell Lymphoma
Next Article in Special Issue
Incidental Findings in Pediatric Patients: How to Manage Liver Incidentaloma in Pediatric Patients
Previous Article in Journal
Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study
 
 
Review

Article Versions Notes

Cancers 2023, 15(2), 508; https://doi.org/10.3390/cancers15020508
Action Date Notes Link
article pdf uploaded. 13 January 2023 14:59 CET Version of Record https://www.mdpi.com/2072-6694/15/2/508/pdf-vor
article xml file uploaded 17 January 2023 10:51 CET Original file -
article xml uploaded. 17 January 2023 10:51 CET Update -
article pdf uploaded. 17 January 2023 10:51 CET Updated version of record https://www.mdpi.com/2072-6694/15/2/508/pdf-vor
article html file updated 17 January 2023 10:52 CET Original file -
article html file updated 17 January 2023 10:54 CET Update -
article xml file uploaded 17 January 2023 11:46 CET Update -
article xml uploaded. 17 January 2023 11:46 CET Update https://www.mdpi.com/2072-6694/15/2/508/xml
article pdf uploaded. 17 January 2023 11:46 CET Updated version of record https://www.mdpi.com/2072-6694/15/2/508/pdf
article html file updated 17 January 2023 11:47 CET Update -
article html file updated 1 March 2023 09:32 CET Update -
article html file updated 7 March 2023 23:12 CET Update https://www.mdpi.com/2072-6694/15/2/508/html
Back to TopTop